Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $16.8700 (0.24%) ($16.8500 - $17.1500) on Thu. Dec. 29, 2005. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.24% (three month average) | RSI | 71 | Latest Price | $16.8700(0.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2% a day on average for past five trading days. | Weekly Trend | BCRX advances 7.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) QQQ(7%) EEM(6%) IWM(6%) SPY(6%) VWO(6%) | Factors Impacting BCRX price | BCRX will decline at least -3.62% in a week (0% probabilities). SHY(-4%) REMX(-2%) TLT(-1%) TIP(-1%) LQD(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.62% (StdDev 7.24%) | Hourly BBV | 0 () | Intraday Trend | 0.1% | | | |
|
5 Day Moving Average | $17.26(-2.26%) | 10 Day Moving Average | $16.27(3.69%) | 20 Day Moving Average | $15.55(8.49%) | To recent high | -4.4% | To recent low | 75% | Market Cap | $2.976b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |